American Oncology Network Inc. (AONC)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in American Oncology Network Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

American Oncology Network Inc. (AONC) has returned 0.00% so far this year and 140.00% over the past 12 months.

Based on dividend-adjusted daily data since May 5, 2021, AONC's average daily return is +0.30%, while the average monthly return is +3.60%. At this rate, your investment would double in approximately 1.6 years.

Historically, 58% of months were positive and 42% were negative. The best month was Jul 2024 with a return of +166.7%, while the worst month was Jun 2024 at -68.6%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 4 months.

On a daily basis, AONC closed higher 34% of trading days. The best single day was Sep 18, 2023 with a return of +168.9%, while the worst single day was Sep 19, 2023 at -52.8%.

American Oncology Network Inc. has an annualized alpha of 109.52%, beta of 0.20, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since May 06, 2021.

• This stock participated in 100.46% of S&P 500 Index downside but only 80.62% of its upside — more exposed to losses than it benefited from rallies.
• Beta of 0.20 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

AONC ranks 82 for risk / return — in the top 82% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for American Oncology Network Inc. (AONC) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the American Oncology Network Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the American Oncology Network Inc. was 96.38%, occurring on Jun 28, 2024. The portfolio has not yet recovered.

The current American Oncology Network Inc. drawdown is 58.62%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of American Oncology Network Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how American Oncology Network Inc. is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.